3 days ago
VTRS
AnalystsJasper HellwegJasper Hellweg's Stock Forecasts
AnalystsJasper Hellweg
Analyst Ranking
Top 26%
#1424 out of 5510 analysts
Average Return
+4.58%
Win Rate
50%30 out of 60
Risk vs Reward
Poor
Good
Jasper Hellweg's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +149.93% | $141.01 | $352.43 | 2020-12-01 - 2021-11-30 | Strong Buy |
Illumina IncILMN | +66.76% | $213.43 | $355.91 | 2017-09-13 - 2018-09-13 | Strong Buy |
Hca Healthcare IncHCA | +63.49% | $79.52 | $130.01 | 2017-08-14 - 2018-08-14 | Strong Buy |
Iqvia Holdings IncIQV | +51.12% | $95.48 | $144.29 | 2018-04-09 - 2019-04-09 | Strong Buy |
Tesaro IncTSRO | +47.15% | $50.94 | $74.96 | 2018-05-02 - 2019-01-18 | Strong Buy |
Jasper Hellweg Analyst Color
Get additional color on Jasper Hellweg's coverage of popular stocks
17 days ago
MRK
a month ago
BMY
2 years ago
SNY
2 years ago
REGN
2 years ago
VRTX
2 years ago
AZN
3 years ago
BIIB
3 years ago
BIIB
3 years ago
AZN
3 years ago
SNY
4 years ago
VRTX
4 years ago
REGN
5 years ago
ELV
Jasper Hellweg's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viatris IncVTRS | 1 | Strong Buy | $20.00 | +21.21% | Maintains | 3 days ago |
Illumina IncILMN | 5 | Strong Buy | $235.00 | +14.63% | Maintains | 8 days ago |
Merck & Co IncMRK | 2 | Strong Buy | $170.00 | +15.23% | Maintains | 17 days ago |
Amgen IncAMGN | 3 | Strong Buy | $460.00 | +17.57% | Maintains | 23 days ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $75.00 | +16.44% | Upgrades | a month ago |
Zoetis IncZTS | 5 | Hold | N/A | N/A | Downgrades | 3 months ago |
Baxter International IncBAX | 2 | Hold | N/A | N/A | Downgrades | 10 months ago |
Biogen IncBIIB | 4 | Hold | N/A | N/A | Downgrades | a year ago |
United Therapeutics CorpUTHR | 4 | Strong Buy | $400.00 | N/A | Maintains | 2 years ago |
SanofiSNY | 2 | Strong Buy | $60.00 | N/A | Maintains | 2 years ago |
Regeneron Pharmaceuticals IncREGN | 5 | Strong Buy | $1,170.00 | N/A | Maintains | 2 years ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $550.00 | N/A | Maintains | 2 years ago |
Astrazeneca PLCAZN | 3 | Strong Buy | $85.00 | N/A | Maintains | 2 years ago |
Novo Nordisk A SNVO | 1 | Strong Buy | $125.00 | N/A | Maintains | 3 years ago |
Moderna IncMRNA | 4 | Strong Buy | $140.00 | N/A | Maintains | 3 years ago |
Veradigm IncMDRX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Abbvie IncABBV | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Cerner CorpCERN | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Elevance Health IncELV | 1 | Strong Buy | $500.00 | N/A | Maintains | 5 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Iqvia Holdings IncIQV | 4 | Strong Buy | $290.00 | N/A | Maintains | 5 years ago |
Integer Holdings CorpITGR | 1 | Strong Buy | $100.00 | N/A | Upgrades | 5 years ago |
Labcorp Holdings IncLH | 3 | Strong Buy | $295.00 | N/A | Maintains | 5 years ago |
Emergent Biosolutions IncEBS | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Quest Diagnostics IncDGX | 1 | Strong Buy | $135.00 | N/A | Upgrades | 6 years ago |
Perrigo Co PLCPRGO | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Equifax IncEFX | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Ligand Pharmaceuticals IncLGND | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Bread Financial Holdings IncBFH | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Hca Healthcare IncHCA | 2 | Strong Buy | $155.00 | N/A | Maintains | 8 years ago |
Manpowergroup IncMAN | 2 | Strong Buy | $95.00 | N/A | Maintains | 8 years ago |
Fiserv IncFISV | 1 | Strong Buy | $90.00 | N/A | Maintains | 8 years ago |
Tesaro IncTSRO | 1 | Strong Buy | $110.00 | N/A | Maintains | 8 years ago |
Blackhawk Network Holdings IncHAWK1 | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Heliogen IncHLGN | 1 | Hold | N/A | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.